BLACKSBURG, Va., Nov. 8, 2017 /PRNewswire/ -- TECHLAB, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received a USDA establishment license and product license for GIARDIA VET CHEK™. The test qualitatively detects Giardia cyst antigen in canine and feline fecal samples and is the first USDA licensed Giardia microwell ELISA available in the US veterinary market.
"The GIARDIA VET CHEK™ allows for large-scale testing of canine and feline in a reference laboratory format; improving workflow and providing timely results," said Joel Herbein, Vice-President of Scientific Affairs at TECHLAB, Inc.
Giardia is a common parasitic cause of diarrhea in dogs and cats.1 The GIARDIA VET CHEK™ test is an automatable enzyme immunoassay optimized for canine and feline fecal samples to aid in the diagnosis of giardiasis. The GIARDIA VET CHEK™ test is the first TECHLAB, Inc. product to be manufactured under the USDA establishment license.
TECHLAB, Inc. (www.techlab.com) has been a leading developer and manufacturer of intestinal diagnostics products in the United States for 27 years. The Company has a market leading portfolio of diagnostic tests for enteric diseases caused by C. difficile, Shiga toxin producing E. coli, and protozoan parasites. TECHLAB also manufactures diagnostic tests for intestinal inflammation and performs diagnostics and life science contract manufacturing and services. TECHLAB is headquartered in Blacksburg, Va. and manufactures its diagnostic tests in the United States at its state-of-the-art manufacturing facility in Radford, Va.
1. The Merck Veterinary Manual. Overview of giardiasis. United States: Merck; 2016
SOURCE TECHLAB, Inc.